Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume 221, Issue 1, Pages 155-169
Publisher
Springer Nature
Online
2012-01-10
DOI
10.1007/s00213-011-2555-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder
- (2011) Leslie Citrome et al. CLINICAL DRUG INVESTIGATION
- Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver
- (2011) Emilie Lauressergues et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: Validation with olanzapine and ziprasidone
- (2010) Miwako Shobo et al. BEHAVIOURAL BRAIN RESEARCH
- Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
- (2010) Michael T. Bailey et al. BRAIN BEHAVIOR AND IMMUNITY
- Lipogenic effects of psychotropic drugs: focus on the SREBP system
- (2010) Johan Ferno Frontiers in Bioscience-Landmark
- Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
- (2010) E F Murphy et al. GUT
- Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis
- (2010) V L Albaugh et al. MOLECULAR PSYCHIATRY
- Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity
- (2010) Thomas B Clarke et al. NATURE MEDICINE
- Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
- (2010) Robert J. Fountaine et al. Obesity
- Preclinical models of antipsychotic drug-induced metabolic side effects
- (2010) Heidi N. Boyda et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effect of Treatment on Weight Gain and Metabolic Abnormalities in Patients with First-Episode Psychosis
- (2009) Swapna Verma et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- (2009) F.C.J. Starrenburg et al. EUROPEAN PSYCHIATRY
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Second-Generation Antipsychotic–Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need
- (2009) Dan Cohen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions
- (2009) Astrid B. Birkenaes et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia
- (2009) Leslie Citrome et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents
- (2009) Sun H. Kim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Lean mean fat reducing “ghrelin” machine: Hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity
- (2009) Harriët Schellekens et al. NEUROPHARMACOLOGY
- The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?
- (2009) Chao Deng et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats
- (2009) Montserrat Victoriano et al. PSYCHOPHARMACOLOGY
- Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
- (2009) Jayendra K. Patel et al. SCHIZOPHRENIA RESEARCH
- Sensitivity of the female rat to olanzapine-induced weight gain—Far from the clinic?
- (2009) Katrina Weston-Green et al. SCHIZOPHRENIA RESEARCH
- Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study
- (2009) Tamás Treuer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome
- (2008) Peter J. Turnbaugh et al. Cell Host & Microbe
- Insulin sensitivity, adjusted β-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: A nine-month prospective study
- (2008) P. Oriot et al. DIABETES & METABOLISM
- Gender Difference in the Composition of Fecal Flora in Laboratory Mice, as Detected by Denaturing Gradient Gel Electrophoresis (DGGE)
- (2008) Seigo FUSHUKU et al. EXPERIMENTAL ANIMALS
- Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia
- (2008) Marilyn Ader et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
- (2008) Stefan Gebhardt et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A core gut microbiome in obese and lean twins
- (2008) Peter J. Turnbaugh et al. NATURE
- Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis
- (2008) Harry J. Flint et al. NATURE REVIEWS MICROBIOLOGY
- Simultaneous Assessment of Soil Microbial Community Structure and Function through Analysis of the Meta-Transcriptome
- (2008) Tim Urich et al. PLoS One
- Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
- (2008) Haruhiko Sugino et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever
- (2008) Michael Kluge et al. PSYCHONEUROENDOCRINOLOGY
- Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver
- (2008) Johan Fernø et al. PSYCHOPHARMACOLOGY
- Insulin resistance following continuous, chronic olanzapine treatment: An animal model
- (2008) Araba F. Chintoh et al. SCHIZOPHRENIA RESEARCH
- Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population
- (2008) Rocio Perez-Iglesias et al. SCHIZOPHRENIA RESEARCH
- Association between antipsychotics and weight gain among psychiatric outpatients in Pakistan: a retrospective cohort study
- (2008) Syed Ahmer et al. Annals of General Psychiatry
- Serotonin 5-HT2CReceptor Agonist Promotes Hypophagia via Downstream Activation of Melanocortin 4 Receptors
- (2007) Daniel D. Lam et al. ENDOCRINOLOGY
- Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain
- (2007) G.D. Cooper et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
- (2007) O. Sentissi et al. SCHIZOPHRENIA BULLETIN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started